Observational studyNeoplasia (New York, N.Y.)2013

ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma.

Laura Arias-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.